共 50 条
- [2] ANXA10 AND ATP7A ARE THE MTOR PATHWAY DOWNSTREAM TO PREDICT THE RECURRENCE AND PROGRESSION IN NON-MUSCLE INVASIVE HIGH GRADE UROTHELIAL CARCINOMA OF THE BLADDER [J]. JOURNAL OF UROLOGY, 2017, 197 (04): : E569 - E569
- [3] NBR1 AND KIF14 ARE THE MTOR PATHWAY DOWNSTREAM TO PREDICT THE RECURRENCE IN NON-MUSCLE INVASIVE LOW GRADE UROTHELIAL CARCINOMA OF THE BLADDER [J]. JOURNAL OF UROLOGY, 2017, 197 (04): : E570 - E570
- [5] A NOVEL NOMOGRAM TO PREDICT BCG RESPONSE IN PATIENTS WITH HIGH-GRADE NON-MUSCLE INVASIVE BLADDER CANCER [J]. JOURNAL OF UROLOGY, 2021, 206 : E298 - E298
- [8] T1 SUBSTAGE IN NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA CAN PREDICT PROGRESSION FREE SURVIVAL [J]. JOURNAL OF UROLOGY, 2020, 203 : E1074 - E1075
- [10] Histological and immunohistochemical markers for progression prediction in transurethrally resected high-grade non-muscle invasive bladder cancer [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (01): : 743 - 750